Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.22 USD | +1.00% | +1.65% | +3.97% |
Apr. 18 | Oppenheimer Raises Avient Price Target to $49 From $45, Maintains Outperform Rating | MT |
Feb. 15 | Deutsche Bank Adjusts Avient Price Target to $42 From $37, Maintains Hold Rating | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- The firm trades with high earnings multiples: 26.91 times its 2024 earnings per share.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.97% | 3.94B | A- | ||
+11.47% | 63.22B | A- | ||
-3.47% | 46.34B | A- | ||
+13.72% | 39.97B | B+ | ||
+17.83% | 25.46B | A- | ||
+7.27% | 18.68B | C+ | ||
-0.57% | 17.24B | B+ | ||
-21.73% | 15.81B | A- | ||
+0.22% | 14.9B | B+ | ||
-19.10% | 13.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AVNT Stock
- Ratings Avient Corporation